Experts Share Common Misconceptions in Their Fields

Video

In Partnership With:

OncLive interviewed experts at the State of the Science Summits™ in February 2020 on common misconceptions in their respective fields.

OncLive interviewed experts at the State of the Science Summits™ in February 2020 on common misconceptions in their respective fields.

Related Videos
Jean L. Koff, MD, MS
Rohan Garje, MD
Debu Tripathy, MD
Benjamin Garmezy, MD
Jeffrey P. Townsend, PhD
Michael Iglesia, MD, PhD
Jean L. Koff, MD, MS
Rohan Garje, MD
Nan Chen, MD
Sundar Jagannath, MBBS
Related Content
Timothy L. Cannon, MD

Pertuzumab Plus Trastuzumab Surpasses Prespecified Activity Threshold in ERBB2/3-Altered Biliary Tract Cancer

May 15th 2024
Article
OncLive On Air

Revisit the OncLive On Air Episodes From February 2024

March 18th 2024
Podcast
Susanna Hegewisch-Becker, MD, PhD

Relatlimab Plus Nivolumab/Chemo Misses ORR End Point in LAG-3+ Advanced Gastric/GEJ Cancer

May 14th 2024
Article
Matthew Galsky, MD

FDA Approval Insights: Enfortumab Vedotin Plus Pembrolizumab in Locally Advanced/Metastatic Urothelial Carcinoma

February 12th 2024
Podcast
Kenneth C. Anderson, MD

The Benefits Outweigh the Risks: Unpacking the Recent ODAC Decisions in Myeloma

May 13th 2024
Article
Mohamad Mohty, MD, PhD, professor, hematology, head, Hematology and Cellular Therapy Department, Saint-Antoine Hospital and Sorbonne University; member, lead, translational research team, Saint-Antoine Research Center; chairman, Acute Leukemia Working Party, EBMT

Ongoing Research Aims to Expand Treatment Options, Address Unmet Needs in GVHD

May 12th 2024
Article